FR2100660B1 - - Google Patents

Info

Publication number
FR2100660B1
FR2100660B1 FR7117104A FR7117104A FR2100660B1 FR 2100660 B1 FR2100660 B1 FR 2100660B1 FR 7117104 A FR7117104 A FR 7117104A FR 7117104 A FR7117104 A FR 7117104A FR 2100660 B1 FR2100660 B1 FR 2100660B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7117104A
Other versions
FR2100660A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2100660A1 publication Critical patent/FR2100660A1/fr
Application granted granted Critical
Publication of FR2100660B1 publication Critical patent/FR2100660B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR7117104A 1970-05-15 1971-05-12 Expired FR2100660B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3789670A 1970-05-15 1970-05-15

Publications (2)

Publication Number Publication Date
FR2100660A1 FR2100660A1 (fr) 1972-03-24
FR2100660B1 true FR2100660B1 (fr) 1975-06-06

Family

ID=21896942

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7117104A Expired FR2100660B1 (fr) 1970-05-15 1971-05-12

Country Status (15)

Country Link
US (1) US3666646A (fr)
AR (1) AR199872A1 (fr)
BE (1) BE767190A (fr)
CA (1) CA985677A (fr)
DE (1) DE2124123A1 (fr)
ES (1) ES391016A1 (fr)
FR (1) FR2100660B1 (fr)
GB (1) GB1355516A (fr)
HU (1) HU164639B (fr)
IE (1) IE35215B1 (fr)
IL (1) IL36772A0 (fr)
NL (1) NL7105076A (fr)
NO (1) NO131754B (fr)
SU (1) SU421202A3 (fr)
ZA (1) ZA712259B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113162B1 (fr) * 1982-09-16 1989-07-19 Hem Research, Inc. Effet antinéoplastiques des acides ds-ribonucléiques sur les cellules des tumeurs
US6780429B1 (en) 1999-02-15 2004-08-24 Nippon Shinyaku Co., Ltd. Chain-shortened polynucleotide and method for preparation thereof
WO2006054129A1 (fr) * 2004-11-19 2006-05-26 Institut Gustave Roussy Traitement ameliore du cancer par arn double brin
AU2005332599B2 (en) * 2005-06-08 2012-02-16 Yisheng Biopharma (Singapore) Pte. Ltd. Polyinosinic acid-polycytidylic acid-based adjuvant
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
EP2116602A1 (fr) 2008-05-07 2009-11-11 Institut Gustave Roussy Combinaison de produits pour traiter le cancer
US20130195919A1 (en) 2010-03-05 2013-08-01 President And Fellows Of Harvard College Induced dendritic cell compositions and uses thereof
EP4329761A1 (fr) 2021-04-28 2024-03-06 ENYO Pharma Potentialisation forte d'effets d'agonistes de tlr3 à l'aide d'agonistes de fxr en tant que traitement combiné

Also Published As

Publication number Publication date
AR199872A1 (es) 1974-10-08
ES391016A1 (es) 1974-04-01
GB1355516A (en) 1974-06-05
IE35215L (en) 1971-11-15
NL7105076A (fr) 1971-11-17
ZA712259B (en) 1972-11-29
US3666646A (en) 1972-05-30
HU164639B (fr) 1974-03-28
CA985677A (en) 1976-03-16
IE35215B1 (en) 1975-12-10
DE2124123A1 (de) 1971-12-02
FR2100660A1 (fr) 1972-03-24
SU421202A3 (ru) 1974-03-25
IL36772A0 (en) 1971-07-28
NO131754B (fr) 1975-04-14
BE767190A (fr) 1971-11-16

Similar Documents

Publication Publication Date Title
AU1473870A (fr)
AU2044470A (fr)
AU2130570A (fr)
AU1517670A (fr)
AU1833270A (fr)
AU1716970A (fr)
AU2017870A (fr)
AU2085370A (fr)
AR195465A1 (fr)
AU1872870A (fr)
AU1974970A (fr)
AU1943370A (fr)
AU1581370A (fr)
AU1591370A (fr)
AU1603270A (fr)
AU1689770A (fr)
AU1832970A (fr)
AU1841070A (fr)
AU1789870A (fr)
AU2144270A (fr)
AU2131570A (fr)
AU2130770A (fr)
AU1879170A (fr)
AU2119370A (fr)
AU2115870A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse